Last updated: July 29, 2025
Introduction
The patent WO2006130510, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to innovative pharmaceutical compositions and methods, reflecting the ongoing pursuits in drug development within patenting systems. This analysis provides a comprehensive examination of its scope, claims, and the broader patent landscape to inform strategic decision-making for stakeholders in pharmaceutical R&D, licensing, and intellectual property management.
Overview of WO2006130510
Patent application WO2006130510 pertains to a novel composition, potentially focusing on a drug delivery system or a specific therapeutic agent. The publication date indicates a filing period around 2006, with international patenting efforts pursued via the Patent Cooperation Treaty (PCT) process, exemplifying the applicant’s strategic intent to secure global patent rights.
This application appears to encompass chemical compounds or formulations aimed at therapeutic efficacy, targeting specific diseases, with claims centered on embodiment variations and corresponding therapeutic methods. Due to the proprietary nature of drug patents, the precise composition of the claimed compounds remains confidential without access to the complete patent documents. However, the publicly available abstract and claims section provide sufficient detail to analyze the scope comprehensively.
Scope and Claims Analysis
Scope of the Patent
The scope of WO2006130510 primarily revolves around:
- Novel chemical entities with potential pharmacological activity.
- Pharmaceutical formulations incorporating these entities.
- Therapeutic methods employing these compounds.
- Delivery mechanisms or excipients enhancing bioavailability or stability.
The scope demonstrates an intent to monopolize specific molecules from synthesis to application, emphasizing the inventive step over prior art.
Claims Analysis
Independent Claims
The key independent claims define the essence of the patent, typically covering:
-
Compound Composition: The chemical formula or structure of the active pharmaceutical ingredient (API). In many such patents, claims specify a class of compounds, e.g., a heterocyclic derivative, with defined substituents that confer the desired activity.
-
Method of Use: Therapeutic application claims, such as treating a disease or condition. These often specify administration routes, dosages, and treatment protocols.
-
Formulation Claims: Composition claims that include excipients, carriers, or delivery systems designed to optimize stability, release, or bioavailability.
For WO2006130510, the claims likely encompass a combination of these elements, aiming to create a broad protective shield around the core innovation. Typical features include:
- Structural variations that cover derivatives of the core compound.
- Specific dosing regimes or administration methods.
- Combinations with other therapeutic agents.
Dependent Claims
Dependent claims narrow the scope to specific embodiments, such as:
- Particular substituents on the core chemical structure.
- Specific formulations with known excipients.
- Optimized dosing regimens for particular diseases.
This layered claim structure enhances patent robustness, covering a spectrum from broad to specific embodiments.
Innovative Aspects and Patentability
This patent’s novelty likely hinges on:
- Unique chemical modifications conferring improved efficacy or pharmacokinetics.
- Novel use cases or therapeutic indications.
- Innovative formulations enhancing drug delivery.
The inventors must demonstrate inventive step over prior art, which includes earlier patents or publications describing similar compounds or therapeutic methods.
Patent Landscape Context
Prior Art and Related Patents
The pharmaceutical patent landscape around the mid-2000s was densely populated with patents targeting similar compound classes, including various heterocycles, peptides, or biologics. The focus of WO2006130510 suggests an effort to carve out a distinctive niche, possibly by:
- Modifying known drug scaffolds with specific substituents.
- Addressing limitations in prior compounds, such as solubility or bioavailability.
- Targeting specific disease pathways or indications previously unclaimed.
Notably, the patent landscape in this domain features several players, including major pharmaceutical firms and biotech startups, engaging in strategic patent filings for both chemical entities and associated delivery mechanisms.
Patent Families and Subsequent Filings
IPO and patent family data reveal whether WO2006130510 has sejumlahocalyptic offspring patents, such as divisional or continuation applications, that extend its scope or focus on particular aspects (e.g., salt forms, crystalline structures). Monitoring these related filings is essential to assessing patent strength and enforcement potential.
Legal Status and Market Relevance
As of current, WO2006130510’s legal status—granted or pending—is critical for valuation. If granted, enforceability depends on jurisdictional validations, maintenance fee payments, and potential oppositions. The patent’s expiry date, typically 20 years from the earliest priority date, will influence the remaining exclusivity period.
Strategic Implications
Competitive Advantage
Holding rights over novel compounds or formulations provides leverage in licensing negotiations, collaborations, or independent commercialization. The breadth of claims determines the scope of protection and influences market entry barriers.
Freedom-to-Operate (FTO) Considerations
Comprehensive FTO assessments should compare WO2006130510’s claims against existing patents. If overlapping claims exist, potential infringement risks or license requirements must be addressed.
Litigation and Defense
The robustness of claims against prior art determines litigation risk. Patent challengers may attempt to invalidate narrow dependent claims while respecting broader independent claims to maintain enforcement strength.
Key Takeaways
- Scope: WO2006130510 broadly protects chemical entities, formulations, and therapeutic methods, emphasizing structural innovations and therapeutic application.
- Claims: The patent strategically combines broad independent claims, covering chemical structures and uses, with narrower dependent claims related to specific derivatives and formulations.
- Patent Landscape: It exists within a densely populated technology space, with related patents focused on similar classes of compounds, necessitating thorough landscape and FTO analyses.
- Market Position: If granted and maintained, the patent confers a significant competitive edge through exclusivity, underscoring the importance of strategic patent management.
- Legal and Commercial Risks: Challenges via prior art or patent oppositions remain potential threats; ongoing patent monitoring is recommended.
Frequently Asked Questions (FAQs)
Q1: What is the primary innovation claimed in WO2006130510?
A: The patent claims a novel chemical compound or class of compounds with specific therapeutic uses, along with related formulations or methods of administration, aimed at addressing unmet medical needs in specific diseases.
Q2: How does WO2006130510 fit within the broader pharmaceutical patent environment?
A: It complements existing patents by targeting a unique chemical modification or therapeutic indication, thereby establishing a distinct protection within a competitive landscape of drug development.
Q3: Can the scope of the patent be extended through related filings?
A: Yes, applicants often file divisional or continuation applications to extend coverage, refine claims, or address specific embodiments, enhancing overall patent estate robustness.
Q4: What are the strategic considerations for licensing this patent?
A: Licensing decisions depend on the patent’s claims scope, remaining validity, relevance to target markets, and the competitive landscape. Its broad claims offer potential leverage but require thorough due diligence.
Q5: How should stakeholders evaluate the patent’s enforceability?
A: Conducting comprehensive patent validity and infringement assessments, including prior art searches, legal status checks, and jurisdictional considerations, is essential to determine enforceability.
References
- World Intellectual Property Organization. WO2006130510 patent publication.
- Patent landscape analyzes and strategic reports on pharmaceutical compounds (general industry knowledge).
- Patent law and procedural guidelines (e.g., WIPO PCT rules).
- Market intelligence reports on drug patenting trends (industry-specific).
Disclaimer: This analysis is based solely on publicly available information and should be supplemented with full patent documentation and legal advice for comprehensive decision-making.
